Do Lower Doses of Targeted Therapy Help Patients with Metastatic Breast Cancer Stay on Treatment Longer?

Home Explore Our Portfolio Do Lower Doses of Targeted Therapy Help Patients with Metastatic Breast Cancer Stay on Treatment Longer? This research project is in progress. PCORI will post the research findings on this page within 90 days after the results are final. Breast cancer is the second most common type of cancer among women. Metastatic breast cancer occurs when cancer cells spread beyond the breast tissue. No cure exists for metastatic breast cancer, but with treatment, people can live with it for

Read the full article here

Source: www.pcori.org

Categories: Partners & KOLs, General Medicine News

Tags: BreastCancer,bcsm,gerionc

Tweets with this article

ASCO

Exciting News! 🚨 Our @PCORI-funded CDK Study has officially enrolled its 1st patient at @IronwoodCancer, a BIG step forward in improving dosing strategies for older adults w/ metastatic #BreastCancer. Learn more: https://t.co/wq6Y9rgoFF #bcsm #gerionc @jrgralow https://t.co/DJoLYhWJoP

Related Articles

Lung Cancer Genetics Study Launched by LCRF, Advocacy Organizations, 23andMe | Docwire News

Twenty lung cancer advocacy organizations will be collaborating with the Lung Cancer Research Foundation (LCRF) and 23andMe Holding Co. to conduct the Lung Cancer Genetics…

December 22, 2024

ATG Plus PTCy: Randomized Pilot Trial Evaluates GVHD Prophylaxis Combination | Cancer Nursing Today

Irwin Walker, MBBS, presented the randomized pilot study to compare ATG alone with ATG plus PTCy at the American Society of Hematology (ASH) 2024 Annual…

Cancer Nursing Today December 22, 2024

Easy-to-make roasted chickpeas are a healthful alternative to high-fat holiday snacks

The mild flavor of canned chickpeas provides a subtle backdrop for a variety of seasonings.

Joel Kahn MD, FACC December 21, 2024

Luspatercept Achieves Clinically Meaningful Outcomes in Lower-Risk MDS | Blood Cancers Today

Luspatercept treatment facilitated hemoglobin levels of 10 g/dL or higher and reduced transfusion dependency in patients with lower-risk myelodysplastic syndromes.

Blood Cancers Today December 21, 2024

Aldi launches its biggest plant-based range for Veganuary

Aldi is launching its largest-ever plant-based range for Veganuary 2025, with a wide selection of new Plant Menu items.

Joel Kahn MD, FACC December 21, 2024

Experts Recommend US Dietary Guidelines Prioritize Plant Protein

An advisory scientific report on US dietary guidelines says that plant-based proteins like beans and nuts should be put before animal protein

Joel Kahn MD, FACC December 21, 2024

Cardiovascular Risk in Prostate Cancer: JACC: CardioOncology State-of-the-Art Review

AbstractCardiovascular disease is common in patients with prostate cancer and is a significant cause of death. Cardiovascular risk factors are frequent in this population and…

JACC Journals December 21, 2024

Associations Between Changes in Maximum Daily Atrial Fibrillation Duration, Ischemic Stroke, and Mortality:

AbstractBackgroundAtrial fibrillation (AF) outcomes are strongly associated with continuous measures of AF burden.ObjectivesThis study sought to assess the association between changes in maximum da…

JACC Journals December 21, 2024

Early Epoetin Alfa Use Improves Outcomes in MDS and Anemia | Blood Cancers Today

The phase 3 EPO-PRETAR trial showed that starting ESAs early in participants with lower-risk MDS and anemia significantly improves hematologic erythroid response and duration.

Blood Cancers Today December 21, 2024

Urine Acid/Base Score for Predicting CKD Progression | Docwire News

Researchers proposed that a urine acid/base score accounting for both the demand and capacity for acid excretion would better predict chronic kidney disease (CKD).

December 21, 2024